Insurance Coverage for Addiction Treatment: 2026 Statistics on Who Is Covered, What Plans Pay, and How Many Facilities Accept Insurance

Whether insurance will pay is the first question most families ask about addiction treatment, and it is usually asked at the worst possible moment. The honest answer is more encouraging than most people expect: federal law requires nearly all health plans to cover substance use disorder treatment, and the share of treatment facilities accepting insurance has climbed every year on record. The gap between coverage on paper and care in practice is real, but it is measurable, and measuring it is exactly what this page does.

Every statistic below comes from a federal survey, a regulation, or a peer-reviewed study, with the source and year noted inline. Nothing here is estimated from industry marketing pages, and nothing is carried forward from the 2015-era numbers that still circulate widely online.

Key numbers at a glance

• 78.3 percent of the 15,953 U.S. substance use treatment facilities accepted private insurance in 2024, up from 75.2 percent in 2021 (SAMHSA, N-SUMHSS 2024 annual report, published 2025).
• 77.8 percent of facilities accepted Medicaid, 52.6 percent accepted Medicare, and 46.9 percent accepted federal military insurance such as TRICARE in 2024; only 1.6 percent accepted no payment of any kind (SAMHSA, N-SUMHSS 2024).
• 48.4 million Americans aged 12 or older (16.8 percent) had a substance use disorder in 2024 (SAMHSA, 2024 NSDUH, published 2025).
• Of the 52.6 million people who needed substance use treatment in 2024, only 19.3 percent (10.2 million) received it (SAMHSA, 2024 NSDUH).
• Among adults who perceived an unmet need for treatment in 2024, 45.3 percent thought it would cost too much, 32.4 percent believed they had no insurance coverage for treatment, and 25.7 percent said their insurance would not pay enough of the cost (SAMHSA, 2024 NSDUH, Table A.56B).
• 37.6 percent of privately insured adults with a drug use disorder did not know whether their plan covered treatment; those who knew they had coverage entered treatment at nearly twice the rate of those without it, 13.4 versus 7.2 percent (Mojtabai et al., PLoS One, 2020).
• 23.1 million people enrolled in ACA Marketplace coverage for 2026, near the record 24.2 million set for 2025; every one of those plans must cover substance use disorder treatment as an essential health benefit (CMS, January 2026; HealthCare.gov, accessed 2026).
• Department of Labor parity enforcement has produced corrections benefiting more than 7.6 million health plan participants across more than 72,000 plans (DOL, 2024 MHPAEA Report to Congress, January 2025).
• In New Hampshire, 96.8 percent of treatment facilities accepted private insurance in 2024; in Massachusetts, 87.2 percent accepted Medicaid. Both figures are well above the national rates (SAMHSA, N-SUMHSS 2024 detailed tables).

How many people with a substance use disorder get treatment

The starting point for every insurance question is the size of the need. In 2024, 48.4 million people aged 12 or older, 16.8 percent of that population, met criteria for a substance use disorder (SUD) in the past year, including 27.9 million with an alcohol use disorder and 28.2 million with a drug use disorder, according to the 2024 National Survey on Drug Use and Health (NSDUH), published by SAMHSA in July 2025.

Counting people who received treatment without a current diagnosis, 52.6 million people (18.2 percent) needed substance use treatment in 2024. Of them, 10.2 million received it, about 1 in 5, or 19.3 percent. Treatment reached people through outpatient care most often (7.1 million people), followed by telehealth (3.6 million), inpatient settings (2.6 million), and medications for opioid or alcohol use disorder (2.2 million and 1.3 million respectively). All figures come from the 2024 NSDUH, and because SAMHSA redesigned its treatment questions in 2022 and again refined them in 2024, these numbers should not be stacked against pre-2022 survey years as a trend.

Insurance sits near the center of that 19.3 percent figure. It is not the leading reason people go without care; most adults with an untreated SUD did not perceive a need for treatment at all (95.6 percent of them, per the 2024 NSDUH). But among the roughly 1.8 million adults who did perceive an unmet need, insurance and cost dominate the practical barriers, a pattern examined in detail later in this article.

What the law requires insurance to cover

Two federal laws set the floor for addiction treatment coverage in the United States.

The Affordable Care Act lists mental health and substance use disorder services among its ten essential health benefits. Per HealthCare.gov, all Marketplace plans must cover behavioral health treatment such as psychotherapy and counseling, inpatient behavioral health services, and substance use disorder treatment. Plans cannot place annual or lifetime dollar limits on these benefits, cannot deny coverage because a substance use disorder is a pre-existing condition, and must begin covering pre-existing conditions the day coverage starts.

The Mental Health Parity and Addiction Equity Act (MHPAEA) of 2008 requires most plans that offer mental health or substance use disorder benefits to cover them no more restrictively than comparable medical and surgical benefits, both financially (copays, deductibles, coinsurance) and in treatment limits (visit caps, prior authorization, network design). The Department of Labor's parity resource hub collects the governing rules and consumer tools.

The population these protections cover keeps growing. CMS reported 23.1 million Marketplace plan selections for 2026, down about 5 percent from the record 24.2 million for 2025 but still roughly double the enrollment of 2021. Worth flagging: many widely read explainer pages about "Obamacare and rehab" still cite marketplace enrollment of 11.7 million and federal poverty levels of $11,770 to $24,250. Those are 2015 numbers. The current HHS poverty guidelines, published January 15, 2026, set the figure at $15,960 for an individual and $33,000 for a family of four in the 48 contiguous states, the thresholds that drive Marketplace subsidies and Medicaid eligibility today.

The 2024 parity rule and where enforcement stands in 2026

No ranking page on this topic covers what has happened to parity regulation since 2024, so here is the sequence, sourced to the primary documents.

On September 23, 2024, the Departments of Labor, Treasury, and Health and Human Services published a final rule strengthening MHPAEA (89 FR 77586, effective November 22, 2024). The rule targeted nonquantitative treatment limitations, or NQTLs, the non-dollar barriers like prior authorization, step therapy, medical necessity standards, and network composition. It prohibited plans from using NQTLs that restrict substance use disorder benefits more than comparable medical benefits, and it required plans to collect and evaluate real outcomes data, then act on "material differences" in access. It also finalized the comparative analyses that plans must hand over to regulators on request under the Consolidated Appropriations Act of 2021.

Then the ground shifted. Following an industry lawsuit, the same three departments announced on May 15, 2025 that they will not enforce the 2024 final rule's new provisions while they reconsider the rule, a pause extending until the litigation concludes plus 18 months. Critically, the departments stated that MHPAEA's statutory obligations, including the comparative-analysis requirements added in 2021, remain fully in effect. The parity floor did not disappear; the newest reinforcement of it is on hold.

What does enforcement look like in practice? The FY 2023 MHPAEA enforcement fact sheet reports that the DOL's Employee Benefits Security Administration closed 102 health plan investigations that fiscal year, reviewed 51 of them for parity compliance, and cited 31 MHPAEA violations across 17 investigations, most involving NQTLs or outright benefit exclusions. Cumulatively, the departments' 2024 Report to Congress (January 2025) credits parity enforcement with corrections that directly benefited more than 7.6 million participants in over 72,000 plans. EBSA holds jurisdiction over roughly 2.6 million private employment-based plans covering about 136 million people, so enforcement capacity, not legal authority, is the practical constraint.

"Patients rarely experience parity as a legal concept. They experience it as whether a prior authorization comes back approved, and how fast. From the clinical side of the desk, the fair test of any parity rule is simple: does someone asking for substance use care face the same process, the same timelines, and the same review standards as someone asking for any other medical treatment? When that is true, treatment starts sooner, and starting sooner is almost always what matters most clinically."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

How many treatment facilities actually accept insurance

This is the question search engines answer worst, because the most-cited federal report on it was built on treatment admissions from 2011, and the most-cited academic series stops in 2018. The current answer comes from SAMHSA's National Substance Use and Mental Health Services Survey (N-SUMHSS), which collected 2024 data from 15,953 U.S. substance use treatment facilities, with results published in 2025.

Source: SAMHSA, N-SUMHSS 2024 annual report (2021 and 2024 survey years). Percentages are of all substance use treatment facilities; only 1.6 percent accepted no payment at all in 2024.

Every insurance category rose between 2021 and 2024. Medicare acceptance climbed more than 7 points, and military insurance acceptance more than 6, the two fastest-growing categories, which tracks with Medicare's new outpatient benefits and expanded veteran community care described below.

Insurance acceptance by level of care

Published federal tables report payment acceptance at the facility level, not by level of care. To close that gap, Clear Steps Recovery analyzed SAMHSA's N-SUMHSS 2024 public use file, which covers 16,047 facilities offering substance use treatment, and computed acceptance rates among facilities offering each level of care. To our knowledge this cross-tabulation is not published anywhere else.

Source: Clear Steps Recovery analysis of the SAMHSA N-SUMHSS 2024 public use file (facilities reporting substance use treatment; telehealth row reflects facilities reporting telemedicine/telehealth use for opioid or other substance use care). Facility counts differ slightly from SAMHSA's published tables, which apply additional edits.

Two patterns deserve attention. First, outpatient levels of care, including intensive outpatient programs, are where insurance acceptance is strongest and broadest across payers. Second, residential facilities accept every form of insurance at the lowest rates, including a private insurance acceptance rate 14 points below IOP and a Medicare acceptance rate under 25 percent. For families comparing options, the practical implication is that coverage questions get easier, not harder, as care moves toward outpatient settings.

For context on how these settings differ clinically, see our guide to inpatient versus outpatient rehab.

"A family can read that a facility accepts their plan and still be surprised by what the plan authorizes. In my experience the practical question is never just whether insurance is accepted. It is which level of care the plan will approve, for how long, and what happens when the clinical picture changes. That is why benefits should be verified against the specific program being recommended, whether that is an intensive outpatient schedule or day treatment, before anyone commits to a start date."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Private insurance coverage trends: 2005 to 2024

The strongest peer-reviewed baseline on private coverage is a 2020 study in PLoS One by Mojtabai and colleagues, which analyzed 11,732 privately insured adults with drug use disorders across the 2005 to 2018 national surveys. Among adults who knew their coverage status, the share reporting that their plan covered drug use disorder treatment rose modestly from 73.5 percent in the pre-ACA years (2005 to 2013) to 77.5 percent after the ACA and parity rules took hold (2014 to 2018). Coverage mattered: insured awareness of coverage was associated with twice the odds of receiving treatment.

That series ends in 2018, and most pages citing it stop there too. The facility-side data above extend the story: between 2021 and 2024 alone, private insurance acceptance at treatment facilities rose from 75.2 to 78.3 percent, Medicaid from 73.2 to 77.8 percent, and Medicare from 45.2 to 52.6 percent (N-SUMHSS 2024). On the demand side, the 2024 NSDUH counts 3.6 million people who received substance use treatment via telehealth, a delivery channel that barely existed when the 2005-2018 series was collected. The direction of travel on coverage is consistent and positive, even as the treatment gap itself remains wide.

Medicaid and Medicare as addiction treatment payers

Medicaid is, in the federal government's own words, "the single largest payer for mental health services in the United States" and is "increasingly playing a larger role in the reimbursement of substance use disorder services" (Medicaid.gov). The facility data bear that out: 77.8 percent of treatment facilities nationally accepted Medicaid in 2024, statistically neck and neck with private insurance, and in expansion states like New Hampshire and Massachusetts the rates run higher still (85.1 and 87.2 percent respectively, per the N-SUMHSS 2024 detailed tables).

Medicare historically had a gap in the middle of the continuum of care: it covered weekly outpatient therapy and inpatient psychiatric care, but nothing between. That changed on January 1, 2024, when CMS established a dedicated intensive outpatient program benefit under the CY 2024 hospital outpatient final rule, allowing IOP services to be furnished in hospital outpatient departments, community mental health centers, federally qualified health centers, and rural health clinics. CMS described the change as closing "a coverage gap when patients require more intense services than traditional outpatient therapy but less than inpatient-level care." Facility behavior responded quickly: Medicare acceptance among treatment facilities jumped from 45.2 percent in 2021 to 52.6 percent in 2024, the largest gain of any payer.

What treatment costs with and without insurance

Search results on rehab costs are dominated by dollar ranges, most commonly a "$10,000 to $50,000" figure, that trace to no primary source, carry no date, and blend levels of care that differ enormously. This page will not repeat an unsourced number. Here is what the primary data actually establish about affordability:

• Cost fear is the single most common practical barrier: 45.3 percent of adults with a perceived unmet need for treatment thought it would cost too much (2024 NSDUH).
• Nearly half of all treatment facilities (46.3 percent) offer treatment at no charge or minimal charge to clients who cannot pay, and 59.8 percent offer a sliding fee scale (N-SUMHSS 2024).
• For insured patients, the binding cost is usually the plan's deductible, copay, and coinsurance structure for the authorized level of care, which varies plan by plan and is exactly what a benefits verification establishes in advance.

For readers without coverage, options are broader than most assume; our guide to who qualifies for free rehab walks through state-funded care, sliding scales, and eligibility.

Uninsured and underinsured: who falls through

The national uninsured backdrop is smaller than many treatment pages imply. Per the CDC's National Center for Health Statistics, 28.0 million people under 65, 10.0 percent, were uninsured in 2025, including 11.6 percent of working-age adults (CDC NCHS FastStats, NHIS early-release estimates). Uninsurance among people with substance use disorders runs higher than the general population's, and the underinsured problem compounds it: in the 2024 NSDUH, 25.7 percent of adults with a perceived unmet treatment need said their insurance would not pay enough of the cost, a distinct problem from having no coverage at all.

The 2026 policy environment adds uncertainty. The enhanced Marketplace subsidies that fueled record enrollment expired at the end of 2025, and 2026 plan selections fell about 5 percent from the 2025 peak (CMS, January 2026). Anyone who loses Marketplace or Medicaid coverage retains options: nearly half of facilities offer free or minimal-cost care to those who cannot pay, and state agencies in New Hampshire and Massachusetts fund treatment access outside the insurance system.

Veterans, TRICARE, and VA Community Care

Military-connected coverage is the least discussed payer lane in addiction treatment statistics, and the fastest changing. Nationally, 46.9 percent of treatment facilities accepted federal military insurance such as TRICARE in 2024, up from 40.3 percent in 2021 (N-SUMHSS 2024). In New Hampshire, that figure is 71.3 percent, among the highest in the country (N-SUMHSS 2024 detailed tables).

Beyond TRICARE, the VA Community Care program lets eligible veterans receive care "from providers in your local community outside of VA" when the VA cannot provide the needed care itself, with VA authorization required in advance. In practice, this means a veteran can often complete an outpatient addiction treatment program near home, paid through the VA, rather than traveling to a VA facility. Clear Steps Recovery serves veterans through a dedicated VA Community Care rehab program, and our overview of veterans' addiction treatment through VA Community Care explains eligibility and referrals step by step.

Telehealth and virtual IOP coverage

Telehealth moved from an emergency measure to a durable, covered layer of the treatment system, and the 2024 data quantify it for the first time in detail:

• 3.6 million people received substance use treatment via telehealth in 2024, and among people with a current SUD, 5.4 percent received treatment that way (2024 NSDUH).
• 80.4 percent of substance use treatment facilities used telemedicine or telehealth in their care in 2024 (N-SUMHSS 2024 detailed tables).
• On the regulatory side, DEA and HHS extended the pandemic-era telemedicine prescribing flexibilities for controlled medications, including buprenorphine for opioid use disorder, through December 31, 2026, the fourth such extension (Federal Register, December 31, 2025).

In our own analysis of the 2024 facility file above, facilities using telehealth accepted private insurance and Medicaid at 81.7 percent each, slightly above the all-facility average, evidence that virtual care is now inside the insured mainstream rather than a cash-pay add-on. For how a virtual program works day to day, see our explainer on virtual intensive outpatient programs.

Dual diagnosis and coverage complexity

Parity law matters most for the people whose care crosses the mental health and substance use line at the same time. In 2024, 21.2 million adults, 8.1 percent, had both a mental illness and a substance use disorder in the past year (2024 NSDUH). Their treatment picture shows how coverage complexity plays out: 41.2 percent received no treatment for either condition, 41.0 percent received mental health treatment only, 3.2 percent received substance use treatment only, and just 14.5 percent, about 3.1 million people, received both.

MHPAEA applies to both benefit categories, so a plan cannot lawfully impose tighter prior authorization or narrower networks on the substance use half of an integrated treatment plan than on comparable medical care. When treatment is combined, benefits verification should confirm coverage for each component, including psychiatric services delivered inside an outpatient addiction program.

New Hampshire and Massachusetts: the state numbers

No national page publishes state-level insurance acceptance for these two states, so the tables below compile them from the N-SUMHSS 2024 detailed tables. New Hampshire had 94 substance use treatment facilities serving 15,401 clients on the March 2024 census date; Massachusetts had 429 facilities serving 88,814 clients.

Source: SAMHSA, N-SUMHSS 2024 detailed tables (Tables SU48b, SU71b, SU78a).

The headline: both states beat the national average on every insurance category. New Hampshire's 96.8 percent private insurance acceptance and 71.3 percent military insurance acceptance are exceptional, while Massachusetts leads on Medicaid (87.2 percent) and Medicare (75.1 percent), consistent with the state's long-standing near-universal coverage policies. Note the flip side for New Hampshire: fewer facilities offer IOP (31.9 percent versus 43.0 nationally), meaning insured Granite Staters may find their plan accepted almost everywhere but the specific level of care they need at fewer doors. State oversight and treatment funding run through the NH Department of Health and Human Services behavioral health programs and the Massachusetts Bureau of Substance Addiction Services.

Why insured people still do not get treatment

Coverage on paper does not automatically become care. Among adults with a substance use disorder who did not receive treatment but recognized they needed it, the 2024 NSDUH recorded these reasons (respondents could name several):

Source: SAMHSA, 2024 NSDUH, Table A.56B.

Notice what the insurance rows actually say. One in three believed they had no coverage for treatment, at a time when essential health benefit rules make that belief incorrect for nearly everyone with a Marketplace, Medicaid, or employer plan. The Mojtabai study quantified the same knowledge gap directly: 37.6 percent of privately insured adults with a drug use disorder did not know whether their plan covered treatment, and people who knew they had coverage entered treatment at nearly double the rate of those without coverage. Network gaps and prior authorization frictions are real, as the parity enforcement record shows, but the most fixable barrier in the data is informational: many people never find out what their plan would pay for.

"When a family tells me they cannot afford treatment, my first question is whether anyone has actually checked their benefits, because very often no one has. People assume a denial before the plan has said a word. I would rather a family spend one phone call learning exactly what their coverage looks like than spend another year assuming it covers nothing. Verification should come before the decision, not after it."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

What this means when you are choosing treatment

The statistics on this page compress into a short practical sequence for anyone weighing treatment:

1. Assume coverage exists until proven otherwise. Essential health benefit rules cover Marketplace and most employer plans; Medicaid acceptance now matches private insurance at the facility level; Medicare covers outpatient care including IOP. Coverage varies by plan, and no outcome is guaranteed, but "my insurance will not cover rehab" is statistically far more likely to be an assumption than a fact.
2. Verify against a specific program and level of care, not a facility name. As the level-of-care data show, acceptance differs meaningfully between outpatient, day treatment, and residential settings. A verification tied to the actual recommended program, like the ones run through our New Hampshire insurance page and Massachusetts insurance page, answers the question that matters.
3. Use the admissions process to surface options, not just prices. A good admissions team will check benefits, explain prior authorization requirements, and identify alternatives (sliding scale, state funding, VA Community Care for veterans) if a plan falls short. If a higher level of care such as medical detox is clinically indicated first, expect a referral to an appropriate detox provider before outpatient treatment begins.

If cravings or withdrawal feel unsafe right now, call or text 988, the Suicide and Crisis Lifeline, which operates around the clock.

Methodology and sourcing notes

Every statistic on this page comes from a primary source: federal survey reports (SAMHSA's 2024 National Survey on Drug Use and Health, published July 2025, and the 2024 National Substance Use and Mental Health Services Survey annual report and detailed tables, published 2025), the Federal Register, Department of Labor enforcement documents, CMS and HHS publications, or a peer-reviewed journal. No figure was taken from treatment industry blogs, directories, or aggregator sites. The level-of-care insurance acceptance table is Clear Steps Recovery's own analysis of SAMHSA's N-SUMHSS 2024 public use file (16,047 facilities reporting substance use treatment); its national marginals were validated against SAMHSA's published figures before publication, and small differences from published tables reflect SAMHSA's additional data edits. NSDUH treatment estimates use the post-2022 redesigned questionnaire and are not compared against earlier survey years. Where federal web pages block automated access (Department of Labor, Medicaid.gov, and the two state agency pages), content was verified against the live pages and archival copies on the date of review. Every citation URL was checked before publication. This page was medically reviewed by Dr. Richard Marasa and last reviewed on July 3, 2026.